Author

Joshua N. Cohen

Amylyx Pharmaceuticals, Inc. (United States)ORCID 0009-0000-5217-0229Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Anton M. SimeonoviD· 1 shared CRIS M. BROWN· 1 shared Fumihiko UranoiD· 1 shared Jeffrey R. MillmaniD· 1 shared Joseph Ekstein· 1 shared Justin B. Klee· 1 shared Kelly KriesiD· 1 shared Kent L. Leslie· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Anton M. SimeonovORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

GeneticsbioRxivPreprintNov 7, 2021

Genotype-phenotype correlation analysis and therapeutic development using a patient stem cell-derived disease model of Wolfram syndrome

Rie Asada Kitamura, Kristina G. Maxwell, Wenjuan Ye…·Fumihiko Urano

This study uses a patient-derived stem cell model to show that a specific WFS1 variant causes mild Wolfram syndrome, which can be treated with chemical chaperones.

DOI 10.1101/2021.11.07.467657

humanexperimental assay

𝕏 PostBluesky